- Published at
- by marketscreener.com
mixed
mixed
Akeso : VOLUNTARY ANNOUNCEMENT - INTERIM ANALYSIS OF THE PHASE III CLINICAL TRIAL OF PENPULIMAB MONOCLONAL ANTIBODY (PD-1) IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE SQUAMOUS NON-SMALL CELL LUNG
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | February 23, 2021